Category: Latest News
-
Apple stock drops after White House trade advisor says company thinks it’s too big to tariff
Apple (NASDAQ:AAPL) shares dipped 0.5% in early trading Wednesday following remarks from White House trade advisor Peter Navarro, who suggested the tech giant believes it is “too big to tariff.” Speaking on Fox Business, Navarro commented on the current trade negotiations, saying, “Apple thinks it’s ’too big to tariff’,” hinting that the company may expect…
-
Microsoft Stock Hits Record High of $501.46 Amid Strong Growth and Strategic Moves
Microsoft Corporation (NASDAQ:MSFT) shares reached a new all-time peak, closing at $501.46. This milestone reflects solid investor confidence fueled by robust revenue growth of 14.13% over the past year and a strong gross profit margin of 69%. Over the last 12 months, Microsoft’s stock climbed 7.33%, demonstrating steady performance in a highly competitive tech landscape.…
-
CoreWeave Leads Market with Scaled Launch of NVIDIA RTX PRO 6000 Blackwells; Shares Rise
CoreWeave Inc. (NASDAQ:CRWV) shares edged up 1.7% on Wednesday after the AI-focused cloud provider became the first to deploy NVIDIA’s new RTX PRO 6000 Blackwell Server Edition at scale. This launch solidifies CoreWeave’s position at the cutting edge of high-performance AI infrastructure, aligning with its ambitious push to dominate GPU cloud services. NVIDIA Corporation (NASDAQ:NVDA)…
-
Hims & Hers Shares Gain on Plans for Canadian Launch Featuring Generic Semaglutide
Hims & Hers Health (NYSE:HIMS) shares climbed 2% on Wednesday following the announcement of its planned market entry into Canada in 2026, timed with the expected global debut of generic semaglutide. The company’s Canadian rollout aims to coincide with the availability of lower-cost generic versions of the widely used weight loss drug, offering potentially significant…
-
Aeluma Shares Surge After Landing Major NASA and U.S. Navy Deals
Aeluma Inc (NASDAQ:ALMU) saw its stock jump 9% following announcements of new contracts with NASA and the U.S. Navy that are set to accelerate the advancement of its cutting-edge quantum and sensing technologies. Under the NASA agreement, Aeluma will push forward the commercialization of entangled photon sources, a key component in the fields of quantum…
-
Plug Power Shares Tick Higher After Securing Extended Hydrogen Supply Deal
Plug Power Inc (NASDAQ:PLUG) saw its shares rise 2.1% after the company announced a long-term extension of its hydrogen supply agreement with a U.S.-based industrial gas partner. The renewed deal ensures access to liquid hydrogen through 2030, a critical component in supporting Plug’s rapidly expanding hydrogen infrastructure. The updated agreement introduces immediate cost savings and…
-
Gilat Shares Edge Higher After Securing Over $22M in Global Satellite Equipment Orders
Shares of Gilat Satellite Networks Ltd. (NASDAQ:GILT) climbed 4.3% after the satellite communications provider announced it has received more than $22 million in new equipment orders from top-tier satellite operators around the world. The incoming orders, which will be fulfilled over the next year, come from multiple customers across different orbital segments—including geostationary (GEO), medium-earth…
-
SU Group Shares Double After Securing Landmark $11.3M Smart Hospital Contract
Shares of SU Group Holdings Limited (NASDAQ:SUGP) surged 125% in pre-market trading following news that the Hong Kong-based security engineering firm has landed the largest deal in its corporate history. Valued at $11.3 million (HK$88.5 million), the newly awarded contract involves deploying an advanced suite of security and monitoring technologies as part of a large-scale…
-
Artelo Biosciences Shares Climb on Promising Preclinical Osteoarthritis Pain Data
Artelo Biosciences Inc (NASDAQ:ARTL) saw its stock jump 10% after unveiling encouraging preclinical results for its lead drug candidate, ART26.12, at the 35th Annual International Cannabinoid Research Society Symposium. The investigational therapy—designed as a non-opioid, non-steroidal fatty acid binding protein 5 (FABP5) inhibitor—demonstrated strong analgesic effects in a model of osteoarthritis pain. According to the…
-
BriaCell Shares Slide 22% After Announcing Dilutive Public Offering
Shares of BriaCell Therapeutics Corp (NASDAQ:BCTX) dropped 22% after the clinical-stage biotech firm unveiled a public offering likely to dilute existing shareholders. The company announced it will offer up to 6,825,938 common units on a best efforts basis, with each unit priced at $2.93. Each unit consists of one common share and one warrant allowing…